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6178 | Analyst, 2014, 139, 6178–6184id quantiﬁcation of DNA
methylation in cancer cells on screen-printed gold
electrodes
Kevin M. Koo,a Abu Ali Ibn Sina,a Laura G. Carrascosa,*a Muhammad J. A. Shiddiky*a
and Matt Trau*ab
Simple, sensitive and inexpensive regional DNA methylation detection methodologies are imperative for
routine patient diagnostics. Herein, we describe eMethylsorb, an electrochemical assay for quantitative
detection of regional DNA methylation on a single-use and cost-eﬀective screen-printed gold electrode
(SPE-Au) platform. The eMethylsorb approach is based on the inherent diﬀerential adsorption aﬃnity of
DNA bases to gold (i.e. adenine > cytosine $ guanine > thymine). Through bisulﬁte modiﬁcation and
asymmetric PCR of DNA, methylated and unmethylated DNA in the sample becomes guanine-enriched
and adenine-enriched respectively. Under optimized conditions, adenine-enriched unmethylated DNA
(higher aﬃnity to gold) adsorbs more onto the SPE-Au surface than methylated DNA. Higher DNA
adsorption causes stronger coulombic repulsion and hinders reduction of ferricyanide [Fe(CN)6]
3ions
on the SPE-Au surface to give a lower electrochemical response. Hence, the response level is directly
proportional to the methylation level in the sample. The applicability of this methodology was tested by
detecting the regional methylation status in a cluster of eight CpG sites within the engrailed (EN1) gene
promoter of the MCF7 breast cancer cell line. A 10% methylation level sensitivity with good
reproducibility (RSD ¼ 5.8%, n ¼ 3) was achieved rapidly in 10 min. Furthermore, eMethylsorb also has
advantages over current methylation assays such as being inexpensive, rapid and does not require any
electrode surface modiﬁcation. We thus believe that the eMethylsorb assay could potentially be a rapid
and accurate diagnostic assay for point-of-care DNA methylation analysis.Introduction
DNA methylation is an epigenetic modication of DNA for
controlling gene expression and maintaining genomic
stability.1–3 In mammals, DNA methylation typically occurs by
an addition of a methyl group onto the h carbon of the
cytosine base within a CpG dinucleotide.4 Aberrant DNA
methylation of the CpG-rich regions in gene promoters has
been regarded as a hallmark in cancer.5 Therefore, an assay for
the rapid detection of DNA methylation could be of aid in early
cancer diagnosis and predisposition.
While many assays have been developed for the early
detection of DNA methylation6–13 on bisulte treated samples,
the majority of these methylation detection techniques usually
involve complex surface chemistries, chemical labels, long
experimental time or relatively tedious experimental proce-
dures. These limitations restrict their use to research settingsstralian Institute for Bioengineering and
ueensland, Qld 4072, Australia. E-mail:
u.au; m.trau@uq.edu.au
nces, The University of Queensland, QLDrather than for clinical usage. Hence, we believe the develop-
ment of a simple, rapid, sensitive and low cost approach for
DNA methylation detection will be ideal for point-of-care or
public health diagnostics.
In order to address the above-mentioned limitations, we
have recently described a novel DNA methylation approach
termed as ‘Methylsorb’14 to quantitatively detect DNA methyl-
ation on bisulte treated DNA. Previous studies have shown that
various DNA bases interact with gold at diﬀerent adsorption
aﬃnities following the adenine > cytosine$ guanine > thymine
trend.15–19 Methylsorb is the rst methylation assay to exploit
the higher adenine-gold adsorption aﬃnity (vs. guanine-gold)
for a simple and rapid measure of methylation status of bisul-
te processed samples without any surface modication.
Through coupling with a surface plasmon resonance (SPR)
readout, methylsorb was able to accurately measure the
regional methylation status in genomic DNA samples down to a
sensitivity of 25% methylation in real-time. Since the under-
lying principle of methylsorb is only dependent on DNA-gold
aﬃnity, we hypothesized that changing to an electrochemical
readout could enable higher detection sensitivity, lower assay
running cost and shorter assay time for a more robust diag-
nostic assay.This journal is © The Royal Society of Chemistry 2014
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View Article OnlineFollowing this line, we engaged the use of inexpensive single-
use screen-printed gold electrodes (SPE-Au) which were fabri-
cated by screen-printing gold inks onto a ceramic substrate.
Screen-printed electrodes have been shown to be ideal for
developing point-of-care assays due to their low cost, dispos-
ability and design exibility as compared to traditional elec-
trode materials.20–22 While various assays have been shown to
integrate SPE-Au into electrochemical biosensors,23 its applica-
tion in DNA methylation detection has yet to be demonstrated.
Herein, we describe a cost-eﬀective electrochemical assay
(referred to as eMethylsorb) for detecting DNA methylation on a
SPE-Au platform. eMethylsorb combines the diﬀerential DNA
base-gold adsorption (aﬃnity) principle with an electro-
chemical readout. Following bisulte modication of DNA
samples to replace unmethylated cytosines with uracils, asym-
metric PCR is used to amplify the DNA sequences. The asym-
metric PCR amplicons consist of adenine-enriched ss-DNA
(unmethylated DNA) and guanine-enriched ss-DNA (methylated
DNA). Unmethylated adenine-enriched amplicons display
higher binding aﬃnity towards the SPE-Au surface as compared
to the guanine-enriched amplicons, thus leading to higher
amount of adsorbed DNA aer a xed time period. A higher
amount of negatively-charged DNA on the electrode surface
results in greater coulombic repulsion with bulk ferricyanide
[Fe(CN)6]
3 ions to give a lower current response during elec-
trochemical detection. Hence, the magnitude of electro-
chemical response in our assay is directly proportional to DNA
methylation level (i.e., the higher the methylation level, the
higher the current response). In this work, experimental
parameters (sample concentration, adsorption time, and pH)
aﬀecting the dynamic range of electrochemical response were
evaluated and optimized. Under optimized conditions, we
successfully used the eMethylsorb approach to measure the
methylation status of eight CpG sites in the engrailed (EN1)
gene promoter of the MCF7 breast cancer cell line.Experimental
Reagents and materials
All reagents were of analytical grade and purchased from Sigma
Aldrich (Australia). UltraPureTM DNase/RNase-free distilled
water (Invitrogen, Australia) was used throughout the experi-
ments. DNA oligonucleotides were purchased from Integrated
DNA Technologies (USA) and sequences are shown in Table 1.
Screen-printed gold electrodes, DRP-C220BT (diameter ¼ 4
mm), were acquired from Dropsens (Spain).Table 1 Sequences of DNA oligonucleotides and primers. CpG sites be
Oligos 50-Se
Methylated sequence GAT
Unmethylated sequence AAT
Asymmetric PCR fwd. primer ATT
Asymmetric PCR rev. primer ACR
This journal is © The Royal Society of Chemistry 2014Preparation of genomic DNA samples
MCF7 breast cancer cell line was purchased from ATCC (USA)
and grown in RPMI 1640 growth media supplemented with 10%
fetal bovine serum in a humidied incubator containing 5%
CO2 at 37 C. Genomic DNA was extracted using the DNeasy
Blood and Tissue DNA extraction kit (Qiagen, Australia). In
addition, 50 ng of human genomic DNA (Roche, Germany) was
amplied using REPLI-g Whole Genome Amplication kit
(Qiagen, Australia) to generate Whole Genomic Amplied
(WGA) DNA samples as 0% methylated DNA standards.Bisulte treatment and asymmetric PCR
Bisulte modication of extracted genomic DNA was performed
using MethyEasyTM Xceed kit (Human Genetics Signatures,
Australia) according to the manufacturer's instructions. In
order to generate ss-DNA amplicons, asymmetric PCR of the
bisulte-treated DNA was performed using AmpliTaq PCR kit
(Applied Biosystems, Australia) with minor modications to
manufacturer's protocol. The asymmetric PCR reaction mix
consisted of 1.5 U AmpliTaq DNA polymerase, 0.7X AmpliTaq
PCR buﬀer,0.2 mM of dNTPs, 125 nM of forward primer
(Table 1), 375 nM of reverse primers (Table 1) and 0.1% Tween.
Thermocycling was carried out under the following conditions:
94 C for 10 min, followed by 50 cycles of 94 C for 30 s, 58 C for
45 s and 72 C for 30 s. Finally, agarose gel electrophoresis was
done to verify amplication.DNA adsorption onto gold electrode surface
For optimization of DNA adsorption conditions and quantita-
tive DNA methylation detection studies, synthetic oligonucleo-
tide sequences (Table 1) were used. The synthetic
oligonucleotides represent fully methylated and unmethylated
bisulte treated and asymmetrically PCR-amplied DNA
sequences of a region containing 8 CpG sites within the EN1
gene promoter. For real samples analysis, asymmetric ampli-
cons derived from the same region of the EN1 gene in MCF7
genomic DNA were used. Experiments with synthetic oligonu-
cleotides were performed by diluting the samples in 5X SSC
buﬀer (0.75M in NaCl, 0.075 M in sodium citrate, pH 7.0, unless
otherwise stated) to give various designated concentrations. For
experiments with real samples, 10 mL of PCR amplicons of
genomic DNA were diluted to 30 mL in 5X SSC buﬀer (pH 7.0).
Then, 30 mL of each sample (synthetic oligonucleotides or PCR
amplicons of genomic DNA) was directly dropped onto the
working electrode surface of a SPE-Au and allowed to adsorb for
10 min (unless otherwise stated) with gentle shaking at rooming interrogated are highlighted in bold and underlined font
quence-30
AACGACGACAATAAAAACGACGCGAAAAA CCCCGAAACGCAAAACACCAA
AACAACAACAATAAAAACAACACAAAAAA CCCCAAAACACAAAACACCAA
CAGTCCACAACAAYGTTGGTTGAGTTTATAA GTAGGATAGT
ACCRCAACAACCAAACCCT
Analyst, 2014, 139, 6178–6184 | 6179
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View Article Onlinetemperature. The electrodes were then washed with 10 mM
phosphate buﬀer (137 mM sodium chloride, 2 mM potassium
chloride, pH 7.4) before electrochemical measurements.Electrochemical measurements
All electrochemical measurements were performed on a
CH1040C potentiostat (CH Instruments, USA) with the three-
electrode system (gold working and counter electrodes, silver
reference electrode) on each SPE-Au. The electrolyte buﬀer
consisted of 10 mM phosphate buﬀer solution (pH 7.4) con-
taining 2.5 mM [Fe(CN)6]
3/[Fe(CN)6]
4 (1 : 1) and 0.1 M KCl.
Diﬀerential pulse voltammetry (DPV) signals were recorded
from 0.1–0.5 V with a pulse amplitude of 50 mV and a pulse
width of 50 ms. The relative change in DPV signal (% i) was
normalized with the response of 0% methylated DNA and was
calculated as follows:
Relative DPV signal change (% i) ¼ [(iM  iUM)/iUM]  100
where iM and iUM are current densities for adsorbed methylated
and unmethylated DNA samples respectively.Results and discussion
eMethylsorb principle
As shown in Scheme 1A, extracted genomic DNA is rstly bisul-
te-treated to convert unmethylated cytosines to uracils. Next,Scheme 1 Schematic representation of eMethylsorb. (A) Methylated
and unmethylated DNA in a sample undergoes bisulﬁte-modiﬁcation
and asymmetric PCR to produce guanine-enriched and adenine-
enriched ss-amplicons respectively. Both ss-amplicons adsorb onto
the SPE-Au surface with diﬀerent adsorption aﬃnities and the amount
of DNA adsorption is detected electrochemically. (B) Higher amount of
unmethylated ss-amplicons adsorption will repel [Fe(CN)6]
3 ions
approaching the electrode surface, and therefore generates a low
Faradaic current at the electrode surface. Therefore, the methylation
level of the sample (increase of % methylation) is directly proportional
to the magnitude of the electrochemical responses generated at the
electrode.
6180 | Analyst, 2014, 139, 6178–6184asymmetric PCR is used to exponentially generate ss-DNA
sequences at the gene of interest. This method of amplication
critically provides only ss-DNA which have been shown to adsorb
faster onto gold surface than ds-DNA.24 Asymmetric PCR also
allows conversion of initial methylated and unmethylated DNA
into guanine-enriched and adenine-enriched DNA sequences
respectively. Adenine-rich oligonucleotides have been observed
to display the highest binding aﬃnity to gold surfaces over other
oligonucleotide sequences.15–19 Due to adenine-gold adsorption
aﬃnity being higher than that of guanine-gold, a higher amount
of adenine-enriched ss-DNA will adsorb onto the working surface
of the SPE-Au. The amount of adsorbed DNA is detected elec-
trochemically by measuring the interfacial electron transfer
reaction of [Fe(CN)6]
3/4 ions on the SPE-Au surface. Although,
this system is usually coupled to the [Ru(NH3)6]
3+/4+ redox system
to improve detection sensitivity, it has been shown previously25
that [Fe(CN)6]
3 ions could still overcome coulombic repulsion
from negatively-charged DNA monolayers to access the electrode
surface if the DNA surface density is adequately low. Our eMet-
hylsorb assay fullls this condition, as DNA adsorption for both
methylated and unmethylated samples lead to signicant but not
complete coulombic repulsion of [Fe(CN)6]
3 ions. However, due
to higher adsorption levels of adenine-enriched (unmethylated)
samples as compare to guanine-enriched (methylated), this
sample type generates the highest coulombic repulsion (i.e., the
lowest current response level). Hence, the methylation status of
the DNA sample directly correlates with the magnitude of the
electrochemical response level.
To demonstrate the eMethylsorb assay, we detected meth-
ylation levels in synthetic DNA samples which were designed to
be similar to bisulte-treated and asymmetric PCR-amplied
target sequences of the EN1 gene. The EN1 gene has been
described as a potential biomarker in several types of cancer26,27
and the eMethylsorb assay was used to quantify the methylation
status at a cluster of eight CpG sites within a span of 53 bases
downstream of the transcription start site of the EN1 gene. As an
initial study, eMethylsorb was performed on synthetic DNA
sequences which were designed to be either 100% methylated
with guanines or 0%methylated with adenines at the eight CpG
sites. As shown on Scheme 1B, the electrode being adsorbed
with 50 nM of guanine-enriched methylated DNA displayed an
approximately 95% larger DPV current response than the
adenine-enriched unmethylated DNA to clearly distinguish
methylated from unmethylated DNA. This result indicates that,
under similar conditions, the amount of adenine-enriched
unmethylated DNA being adsorbed onto the working SPE-Au
surface is higher, thus reducing surface electron transfer to give
a lower DPV current response. Our nding is also in good
agreement with our previous study which used a SPR readout14
as well as other studies which observed base-dependent oligo-
nucleotide adsorption (i.e., adenine > cytosine $ guanine >
thymine) onto gold surfaces.15,17–19Optimization of eMethylsorb experimental conditions
In order to maximize the signal/noise ratio to achieve maximal
response diﬀerence between methylated and unmethylatedThis journal is © The Royal Society of Chemistry 2014
Fig. 1 Optimization of DNA adsorption conditions. Variance of % i
(current response diﬀerence) between methylated and unmethylated
DNA with (A) DNA concentration used for adsorption, (B) adsorption
time, (C) pH of adsorption solution. Each data point represents the
average of the three separate trials (n ¼ 3) and error bars represent
standard error within each experiment.
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View Article OnlineDNA samples (i.e. largest % i), we optimized the DNA concen-
tration, time and pH of the DNA adsorption process (Fig. 1). The
optimization of DNA concentration was carried out by adsorb-
ing methylated or unmethylated synthetic oligonucleotides of
various concentrations (10–250 nM) onto separate SPE-Au
surfaces for 10 min at pH 7.0. As shown on Fig. 1A, a 42%
change in DPV signals between methylated and unmethyated
DNA (% i) was observed even at the lowest tested DNA
concentration (i.e., 10 nM). This result highlights the good
sensitivity of the eMethylsorb assay in discriminating the more
highly-adsorbed unmethylated sequences from methylated
sequences even at low concentration. A further enhancement to
92% i was observed by using 50 nM concentration but any
higher concentration result in sharp decrease of % i, with the
250 nM concentration only generating a 17% i. These data
clearly indicate that concentration levels above 50 nM lead to
similar current response levels for both methylated and
unmethylated sequences, thus resulting in diﬃculty dis-
tinguishing methylated from unmethylated sequences. This is
possibly due to saturation of both sequences on the electrodes
surfaces at higher concentrations which subsequently induce
similar level of coulombic repulsion between the bulk
[Fe(CN)6]
3 ions and surface-bound DNA (i.e. similar current
response levels). Thus, 50 nM DNA concentration was used for
subsequent adsorption time and pH experiments.
The eﬀect of time on DNA adsorption was studied by incu-
bating 50 nM of methylated or unmethylated synthetic oligo-
nucleotides onto separate SPE-Au surfaces over a range of
diﬀerent time periods (5–60 min) at pH 7.0. As shown in Fig. 1B,
a 78% i between methylated and unmethylated sequences was
observed aer only 5 min of adsorption time. The highest level
of 94% i was observed aer 10 min adsorption time and
subsequent extended adsorption time resulted in reduced % i,
with 60 min adsorption time giving the lowest level of 18% i.
The % i decrease aer prolonged adsorption time could also be
due to adsorption saturation of both methylated andThis journal is © The Royal Society of Chemistry 2014unmethylated sequences (i.e., similar level of coulombic
repulsion between the bulk [Fe(CN)6]
3 ions and surface-bound
DNA). Therefore, for better discrimination between methylated
and unmethylated current responses, 10 min was selected as
the optimal adsorption time for the eMethylsorb assay.
Finally, the eﬀect of buﬀer pH on the DNA adsorption
process was studied by adsorbing 50 nM of methylated or
unmethylated DNA oligonucleotides onto separate gold elec-
trodes for 10 min over a range of pH (4.7–11.5). Fig. 1C shows
that the % i increased from 30% at pH 4.7 to a maximal 92% at
pH 7.0 and then began to decrease for pH above 7. Our data
suggested that buﬀer pH aﬀects the competition between DNA-
gold electrostatic forces and inherent DNA bases-gold binding
aﬃnities. At basic pH (i.e., above pH 7.0), the gold surface
would be more negatively-charged and electrostatic repulsion
with the negatively-charged phosphate backbone of DNA could
occur to reduce overall DNA adsorption (i.e. lower % i). In
contrast, at low acidic pH, adenines and cytosines in the
oligonucleotide sequences would be protonated and display
higher adsoption aﬃnity for gold.28,29 This issue, coupled with
the less negatively-charged gold surface at low pH, could favor
higher DNA adsorption of both methylated and unmethylated
sequences to give lower diﬀerence between their respective
electrochemical responses. However, at pH 7.0, the superior
adsorption aﬃnity of unmethylated sequences could still occur
due to suﬃcient protonation of adenines and screening of
negative charges by positive ions in the buﬀer to reduce elec-
trostatic repulsion. Therefore, we reasoned that neutral pH 7.0
represents the most suitable condition for obtaining higher
adsorbed amount of adenine-enriched unmethylated
sequences over methylated sequences to maximize response
change and selected pH 7.0 as the ideal adsorption pH for
eMethylsorb.Sensitivity of eMethylsorb for heterogeneous methylation
detection
Heterogeneous DNAmethylation30 is a common event in cancer.
During cancer development, DNA methylation level across CpG
regions occurs as a gradual process31 with high methylation
levels usually observed at the advanced stages. Furthermore,
tissue biopsies usually consist of a mix of diseased and healthy
cells, thus leading to a mixture of methylated and unmethylated
DNA within a patient sample. Taken together, for early cancer
detection, it is essential for an assay to be highly sensitive for
detecting a low amount of methylated DNA in a high back-
ground of unmethylated DNA. In order to simulate this situa-
tion for our eMethylsorb assay, we mixed diﬀerent volume
ratios of methylated and unmethylated synthetic sequences to
create samples of diﬀerent %methylation (0%, 10%, 25%, 50%,
75%, 90%, and 100%). These samples were adsorbed onto
surfaces of SPE-Au under optimized conditions and subjected to
DPVmeasurements. As shown in Fig. 2A, DPV current responses
displayed an increasing trend with higher DNA methylation
levels. This supports the eMethylsorb principle of using
adsorption of diﬀerent amount of adenine-enriched DNA
sequences to estimate DNA methylation level. In addition, theAnalyst, 2014, 139, 6178–6184 | 6181
Fig. 2 (A) Diﬀerential pulse voltammograms corresponding to
diﬀerent % methylated synthetic oligonucleotide sequences. (B) % i
(current response diﬀerence) for synthetic oligonuceotides at 0%, 10%,
25%, 50%, 75%, 90% and 100% methylation. Each bar graph represents
the average of the three separate trials (n ¼ 3) and error bars represent
standard error within each experiment.
Fig. 3 (A) Diﬀerential pulse voltammograms corresponding to
diﬀerent % methylated DNA samples derived from MCF7 and whole
genome ampliﬁed (WGA) genomic DNA. (B) % i (current response
diﬀerence) for MCF7- and WGA-derived genomic DNA samples at 0%,
10%, 25%, 50%, 75% and 100% methylation. Each bar graph represents
the average of the three separate trials (n ¼ 3) and error bars represent
standard error within each experiment.
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View Article OnlineeMethylsorb assay was sensitive to 10% methylation, showing
an associated response change of 6.9% above background
signal (Fig. 2B). Considering that only a total of eight CpG sites
were being interrogated, this detection limit demonstrates high
sensitivity of the eMethylsorb assay in accurately quantifying
DNA methylation. It is worthy to highlight the good sensitivity
of eMethylsorb was achieved without costly uorescence labels
used in majority of current methylation detection
techniques.8,32–34
Furthermore, eMethylsorb does not involve any time-
consuming electrode surface modication and does not require
any complex data analysis. Our eMethylsorb detection tech-
nique is also not limited to availability of methylation-sensitive
restriction enzyme sites used in other methylation assays.6,35,36
Moreover, the RSD over three independent eMethylsorb assays
with single-use disposable SPE-Au is 5.3% (Fig. 2B), showing
good assay reproducibility. As the electrodes are of single usage,
there is no need for time-consuming cleaning of electrodes aer
each round of experiments to reduce surface modication
variability and subsequently, data reproducibility. In all, the
low detection limit and good reproducibility shows that
eMethylsorb is a potential methylation assay for clinical
applications.6182 | Analyst, 2014, 139, 6178–6184eMethylsorb analysis of tumour cell line methylation
To test the application potential and analytical reproducibility
of the eMethylsorb assay on real samples, we investigated the
methylation status of the eight CpG sites within the EN1 gene of
human breast cancer cell line MCF7 which have been reported
to be methylated in MCF7 cells.9 DNA amplicons generated
from WGA were used as unmethylated DNA (i.e. adenine-
enriched) standards. In a similar manner to previous experi-
ments with synthetic DNA samples, we also attempted to test
the eMethylsorb assay's potential in detecting diﬀerent levels of
DNA methylation in a mixture of methylated and unmethylated
DNA. Aer bisulte conversion of the MCF7 and WGA genomic
DNA, samples of diﬀerent methylation levels (0%, 10%, 25%,
50%, 75% and 100%) were prepared through mixing both at
diﬀerent ratios. The genomic DNA samples were then asym-
metrically amplied and analyzed by eMethylsorb under the
optimized conditions. As shown in Fig. 3A, there is a corre-
sponding increase in DPV current response with increasing
methylation level in the DNA samples. This trend is identical to
the eMethylsorb assay results using diﬀerent % methylated
oligonucleotides (Fig. 3) and shows that the assay can be used
for quantitative methylation detection in cancer cells. Fig. 3BThis journal is © The Royal Society of Chemistry 2014
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View Article Onlineshows that the diﬀerence in electrochemical response between
the 100% methylated MCF7 genomic DNA and 0% methylated
WGA DNA is approximately 230%. This response change is
more than two-fold improvement from the response change
obtained using fully methylated and unmethylated synthetic
sequences (Fig. 3B). This could be explained by PCR amplicons
of MCF7 DNA and WGA DNA (140 bp) being longer in length
than synthetic sequences (53 bp). Longer sequences could
promote adsorption of adenines in unmethylated sequences
while concurrently decrease lower-aﬃnity guanine adsorption
in methylated sequences. This would lead to a higher and better
dynamic range of electrochemical response during detection.
The detection sensitivity is 10% methylation with a RSD of 5.8%
(n ¼ 3), demonstrating sensitivity and reproducibility as a
potential diagnostic assay for detecting heterogeneously
methylated DNA in real samples.Conclusions
We have developed a simple, economical and label-free
approach for the detection and quantication of DNA methyl-
ation in extracted genomic DNA from a breast cancer cell line.
The eMethylsorb assay is based on the diﬀerential adsorption
(aﬃnity) of nucleotides on a gold surface and for the rst time,
combined with the SPE-Au platform to rapidly interrogate
regional DNA methylation within a gene. We have demon-
strated the feasibility of this technique to sensitively (10%
methylation across eight CpG sites) and specically detect
methylated DNA in a heterogeneous cancer cell line sample. We
believe the eMethylsorb assay has potential for diagnostics
applications in the early detection of DNA methylation in
diseases.Conﬂict of interest
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